Pooled analysis of the prognostic and predictive effects of TP53 comutation status combined with KRAS or EGFR mutation in early-stage resected non-small-cell lung cancer in four trials of adjuvant chemotherapy
Frances A. Shepherd, Benjamin Lacas, Gwénäel Le Teuff, Pierre Hainaut, Pasi A. Jänne, Jean Pierre Pignon, Thierry Le Chevalier, Lesley Seymour, Jean Yves Douillard, Stephen Graziano, Elizabeth Brambilla, Robert Pirker, Martin Filipits, Robert Kratzke, Jean Charles Soria, Ming Sound Tsao
Dive into the research topics of 'Pooled analysis of the prognostic and predictive effects of TP53 comutation status combined with KRAS or EGFR mutation in early-stage resected non-small-cell lung cancer in four trials of adjuvant chemotherapy'. Together they form a unique fingerprint.